337 related articles for article (PubMed ID: 21209106)
21. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion.
Sharma-Walia N; Paul AG; Bottero V; Sadagopan S; Veettil MV; Kerur N; Chandran B
PLoS Pathog; 2010 Feb; 6(2):e1000777. PubMed ID: 20169190
[TBL] [Abstract][Full Text] [Related]
22. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
23. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.
Miller G; Heston L; Grogan E; Gradoville L; Rigsby M; Sun R; Shedd D; Kushnaryov VM; Grossberg S; Chang Y
J Virol; 1997 Jan; 71(1):314-24. PubMed ID: 8985352
[TBL] [Abstract][Full Text] [Related]
24. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
25. X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma.
Lai IY; Farrell PJ; Kellam P
J Gen Virol; 2011 Feb; 92(Pt 2):421-31. PubMed ID: 20980528
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells.
Raghu H; Sharma-Walia N; Veettil MV; Sadagopan S; Chandran B
J Virol; 2009 May; 83(10):4895-911. PubMed ID: 19279100
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.
Xu D; Coleman T; Zhang J; Fagot A; Kotalik C; Zhao L; Trivedi P; Jones C; Zhang L
J Virol; 2007 Jun; 81(11):6068-78. PubMed ID: 17376914
[TBL] [Abstract][Full Text] [Related]
28. Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells.
Landis JT; Tuck R; Pan Y; Mosso CN; Eason AB; Moorad R; Marron JS; Dittmer DP
mBio; 2022 Feb; 13(1):e0347321. PubMed ID: 35089062
[TBL] [Abstract][Full Text] [Related]
29. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus.
Chiou CJ; Poole LJ; Kim PS; Ciufo DM; Cannon JS; ap Rhys CM; Alcendor DJ; Zong JC; Ambinder RF; Hayward GS
J Virol; 2002 Apr; 76(7):3421-39. PubMed ID: 11884567
[TBL] [Abstract][Full Text] [Related]
30. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.
Sadagopan S; Sharma-Walia N; Veettil MV; Raghu H; Sivakumar R; Bottero V; Chandran B
J Virol; 2007 Apr; 81(8):3949-68. PubMed ID: 17287275
[TBL] [Abstract][Full Text] [Related]
32. Kaposi's sarcoma-associated herpesvirus induces Nrf2 during de novo infection of endothelial cells to create a microenvironment conducive to infection.
Gjyshi O; Bottero V; Veettil MV; Dutta S; Singh VV; Chikoti L; Chandran B
PLoS Pathog; 2014 Oct; 10(10):e1004460. PubMed ID: 25340789
[TBL] [Abstract][Full Text] [Related]
33. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells.
Lagunoff M; Bechtel J; Venetsanakos E; Roy AM; Abbey N; Herndier B; McMahon M; Ganem D
J Virol; 2002 Mar; 76(5):2440-8. PubMed ID: 11836422
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.
Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324
[TBL] [Abstract][Full Text] [Related]
35. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.
Spadavecchia S; Gonzalez-Lopez O; Carroll KD; Palmeri D; Lukac DM
J Virol; 2010 Oct; 84(20):10488-500. PubMed ID: 20686042
[TBL] [Abstract][Full Text] [Related]
36. The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters.
Groves AK; Cotter MA; Subramanian C; Robertson ES
J Virol; 2001 Oct; 75(19):9446-57. PubMed ID: 11533207
[TBL] [Abstract][Full Text] [Related]
37. Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.
An FQ; Folarin HM; Compitello N; Roth J; Gerson SL; McCrae KR; Fakhari FD; Dittmer DP; Renne R
J Virol; 2006 May; 80(10):4833-46. PubMed ID: 16641275
[TBL] [Abstract][Full Text] [Related]
38. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.
Ciufo DM; Cannon JS; Poole LJ; Wu FY; Murray P; Ambinder RF; Hayward GS
J Virol; 2001 Jun; 75(12):5614-26. PubMed ID: 11356969
[TBL] [Abstract][Full Text] [Related]
39. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.
Xie J; Ajibade AO; Ye F; Kuhne K; Gao SJ
Virology; 2008 Feb; 371(1):139-54. PubMed ID: 17964626
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
Paul AG; Chandran B; Sharma-Walia N
Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
